• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

母胎中抗 SARS-CoV-2 中和抗体与其他病原体总抗体的转移比较。

Transplacental transfer of anti-SARS-CoV-2 neutralizing antibodies in comparison to other pathogens total antibodies.

机构信息

Université Paris-Saclay, Inserm U1193, AP-HP, Hôpital Paul Brousse, Virology department, Villejuif 94800, France; Groupe de Recherche sur les Infections pendant la Grossesse (GRIG), France.

Université Paris Cité, INSERM CIC-EC 1425, AP-HP, Hôpital Bichat - Claude Bernard, Clinical Research Department, France.

出版信息

J Clin Virol. 2023 Aug;165:105495. doi: 10.1016/j.jcv.2023.105495. Epub 2023 May 26.

DOI:10.1016/j.jcv.2023.105495
PMID:37295035
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10212596/
Abstract

BACKGROUNDS

Due to immaturity of their immune system, passive maternal immunization is essential for newborns during their first months of life. Therefore, in the current context of intense circulation of SARS-CoV-2, identifying factors influencing the transfer ratio (TR) of neutralizing antibodies against SARS-CoV-2 (NAb) appears important.

METHODS

Our study nested in the COVIPREG cohort (NCT04355234), included mothers who had a SARS-CoV-2 PCR positive during their pregnancy and their newborns. Maternal and neonatal NAb levels were measured with the automated iFlash system.

RESULTS

For the 173 mother-infant pairs included in our study, the median gestational age (GA) at delivery was 39.4 weeks of gestation (WG), and 29.7 WG at maternal SARS-CoV-2 infection. Using a multivariate logistic model, having a NAb TR above 1 was positively associated with a longer delay from maternal positive SARS-CoV-2 PCR to delivery (aOR 1.09, 95% CI: 1.03 - 1.17) and with a later GA at delivery (aOR = 1.58, 95% CI: 1.09 - 2.52). It was negatively associated with being a male newborn (aOR 0.21, 95% CI: 0.07 - 0.59). In 3rd trimester SARS-CoV-2 infected mothers, NAb TR was inferior to VZV, toxoplasmosis, CMV, measle and rubella's TR. However, in 1st or 2nd trimester infected mothers, only measle TR was different from NAb TR.

CONCLUSION

Male newborn of mothers infected by SARS-CoV-2 during their pregnancy appear to have less protection against SARS-CoV-2 in their first months of life than female newborns. Measle TR was superior to NAb TR even in case of 1st or 2nd trimester maternal SARS-CoV-2 infection. Future studies are needed to investigate possible differences in transmission of NAb following infection vs vaccination and its impact on TR.

摘要

背景

由于新生儿免疫系统尚未成熟,因此在生命的头几个月中,被动的母体免疫对于新生儿至关重要。因此,在当前 SARS-CoV-2 强烈传播的情况下,确定影响 SARS-CoV-2 中和抗体(NAb)转移率(TR)的因素显得尤为重要。

方法

我们的研究嵌套在 COVIPREG 队列中(NCT04355234),纳入了在怀孕期间 SARS-CoV-2 PCR 阳性的母亲及其新生儿。使用自动化 iFlash 系统测量了母婴的 NAb 水平。

结果

在我们的研究中,有 173 对母婴被纳入,中位分娩时的胎龄(GA)为 39.4 周 GA,母亲 SARS-CoV-2 感染时为 29.7 周 GA。使用多元逻辑模型,NAb TR 大于 1 与从母亲 SARS-CoV-2 PCR 阳性到分娩的时间延迟较长(优势比 1.09,95%CI:1.03-1.17)和分娩时 GA 较晚相关(优势比为 1.58,95%CI:1.09-2.52)。它与新生儿为男性呈负相关(优势比 0.21,95%CI:0.07-0.59)。在妊娠晚期感染 SARS-CoV-2 的母亲中,NAb TR 低于 VZV、弓形虫病、CMV、麻疹和风疹的 TR。然而,在妊娠 1 期或 2 期感染的母亲中,只有麻疹 TR 与 NAb TR 不同。

结论

与女性新生儿相比,在妊娠期间感染 SARS-CoV-2 的母亲的男婴在生命的头几个月中对 SARS-CoV-2 的保护作用似乎较弱。即使在妊娠 1 期或 2 期感染 SARS-CoV-2 的情况下,麻疹 TR 也优于 NAb TR。未来的研究需要调查感染后与接种疫苗后 NAb 的传播差异及其对 TR 的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cfd/10212596/96e7b5f5e401/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cfd/10212596/1ac02acf7268/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cfd/10212596/293eca7ea10b/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cfd/10212596/bbca141cc5ae/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cfd/10212596/96e7b5f5e401/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cfd/10212596/1ac02acf7268/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cfd/10212596/293eca7ea10b/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cfd/10212596/bbca141cc5ae/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cfd/10212596/96e7b5f5e401/gr4_lrg.jpg

相似文献

1
Transplacental transfer of anti-SARS-CoV-2 neutralizing antibodies in comparison to other pathogens total antibodies.母胎中抗 SARS-CoV-2 中和抗体与其他病原体总抗体的转移比较。
J Clin Virol. 2023 Aug;165:105495. doi: 10.1016/j.jcv.2023.105495. Epub 2023 May 26.
2
BM study: a monocentric prospective observational cohort study on neonatal humoral immunity against COVID-19 secondary to transplacental antibody transfer and breastfeeding.BM研究:一项关于经胎盘抗体转移和母乳喂养继发的新生儿针对新冠病毒的体液免疫的单中心前瞻性观察队列研究。
Ital J Pediatr. 2025 Jul 1;51(1):203. doi: 10.1186/s13052-025-02042-3.
3
COVID-19 Vaccines2019冠状病毒病疫苗
4
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低人类免疫缺陷病毒感染母婴传播风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2007 Jan 24(1):CD003510. doi: 10.1002/14651858.CD003510.pub2.
5
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低艾滋病毒感染母婴传播风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2011 Jul 6(7):CD003510. doi: 10.1002/14651858.CD003510.pub3.
6
Safety of SARS-CoV-2 vaccination during pregnancy- obstetric outcomes from a large cohort study.SARS-CoV-2 疫苗接种在妊娠期间的安全性-来自大型队列研究的产科结局。
BMC Pregnancy Childbirth. 2022 Feb 28;22(1):166. doi: 10.1186/s12884-022-04505-5.
7
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
8
SARS-CoV-2 Infection and Adverse Maternal and Perinatal Outcomes: Time-to-Event Analysis of a Hospital-Based Cohort Study of Pregnant Women in Rio de Janeiro, Brazil.严重急性呼吸综合征冠状病毒2感染与不良孕产妇及围产期结局:巴西里约热内卢一项基于医院的孕妇队列研究的事件发生时间分析
Viruses. 2025 Jan 31;17(2):207. doi: 10.3390/v17020207.
9
Placental transfer of SARS-CoV-2 antibodies in mother-neonate pairs: a prospective nested cohort study.母婴对中 SARS-CoV-2 抗体的胎盘转运:一项前瞻性巢式队列研究。
BMC Infect Dis. 2025 Jul 1;25(1):875. doi: 10.1186/s12879-025-11225-6.
10
Anti-SARS-CoV-2 total immunoglobulin and neutralising antibody responses in healthy blood donors throughout the COVID-19 pandemic: a longitudinal observational study.在整个 COVID-19 大流行期间健康献血者的抗 SARS-CoV-2 总免疫球蛋白和中和抗体反应:一项纵向观察研究。
Swiss Med Wkly. 2024 Jul 1;154:3408. doi: 10.57187/s.3408.

引用本文的文献

1
The Effectiveness and Influence of COVID-19 Vaccination on Perinatal Individuals and Their Newborns: An Updated Meta-Analysis.新冠病毒疫苗接种对围产期个体及其新生儿的有效性和影响:一项更新的荟萃分析
Can J Infect Dis Med Microbiol. 2025 Jun 24;2025:6115890. doi: 10.1155/cjid/6115890. eCollection 2025.
2
Factors modulating maternofetal transfer of IgG antibodies following SARS-CoV-2 gestational infection.新冠病毒孕期感染后调节IgG抗体母婴转运的因素
Rev Inst Med Trop Sao Paulo. 2025 Apr 14;67:e29. doi: 10.1590/S1678-9946202567029. eCollection 2025.
3
Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women.

本文引用的文献

1
Validation of a SARS-CoV-2 Surrogate Virus Neutralization Test in Recovered and Vaccinated Healthcare Workers.验证 SARS-CoV-2 替代病毒中和试验在康复和接种疫苗的医护人员中的效果。
Viruses. 2023 Feb 2;15(2):426. doi: 10.3390/v15020426.
2
Neutralizing antibody activity against SARS-CoV-2 variants in gestational age-matched mother-infant dyads after infection or vaccination.感染或接种疫苗后,与妊娠年龄匹配的母婴对 SARS-CoV-2 变体的中和抗体活性。
JCI Insight. 2022 Jun 22;7(12):e157354. doi: 10.1172/jci.insight.157354.
3
Evaluation of commercial Anti-SARS-CoV-2 neutralizing antibody assays in seropositive subjects.
未接种疫苗孕妇的 SARS-CoV-2 抗体血清阳性率与胎盘转移。
BMC Infect Dis. 2024 May 21;24(1):509. doi: 10.1186/s12879-024-09399-6.
4
Hybrid Immunity to SARS-CoV-2 During Pregnancy Provides More Durable Infant Antibody Responses Compared to Natural Infection Alone.妊娠期 SARS-CoV-2 混合免疫产生的抗体应答比单纯自然感染更持久,能为婴儿提供更好的保护。
J Infect Dis. 2024 Jun 14;229(6):1728-1739. doi: 10.1093/infdis/jiad592.
评估在血清阳性个体中商业化的抗 SARS-CoV-2 中和抗体检测试剂盒。
J Clin Virol. 2022 Jul;152:105169. doi: 10.1016/j.jcv.2022.105169. Epub 2022 Apr 27.
4
Preliminary results on transmission of SARS-CoV-2 antibodies to the fetus and serum neutralizing activity.SARS-CoV-2 抗体向胎儿的传递和血清中和活性的初步结果。
Int J Gynaecol Obstet. 2022 Aug;158(2):476-478. doi: 10.1002/ijgo.14185. Epub 2022 Apr 6.
5
SARS-CoV-2 positivity in offspring and timing of mother-to-child transmission: living systematic review and meta-analysis.SARS-CoV-2 阳性在后代中的出现及母婴传播的时间:系统综述和荟萃分析。
BMJ. 2022 Mar 16;376:e067696. doi: 10.1136/bmj-2021-067696.
6
Risk Factors for Severe COVID-19 in Children.儿童重症 COVID-19 的危险因素。
Pediatrics. 2022 Jan 1;149(1). doi: 10.1542/peds.2021-053418. Epub 2021 Dec 22.
7
Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort study.妊娠期第三 trimester接种 SARS-CoV-2 疫苗和胎盘抗体转移的时间:一项前瞻性队列研究。
Clin Microbiol Infect. 2022 Mar;28(3):419-425. doi: 10.1016/j.cmi.2021.10.003. Epub 2021 Nov 3.
8
Performance of a Surrogate SARS-CoV-2-Neutralizing Antibody Assay in Natural Infection and Vaccination Samples.替代SARS-CoV-2中和抗体检测在自然感染和疫苗接种样本中的性能
Diagnostics (Basel). 2021 Sep 24;11(10):1757. doi: 10.3390/diagnostics11101757.
9
Maternal SARS-CoV-2 infection elicits sexually dimorphic placental immune responses.母体感染 SARS-CoV-2 会引起有性二态性胎盘免疫反应。
Sci Transl Med. 2021 Oct 27;13(617):eabi7428. doi: 10.1126/scitranslmed.abi7428.
10
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2.辉瑞-BioNTech 两剂疫苗接种后 COVID-19 患者和疫苗接种者的中和抗体。
Viruses. 2021 Jul 14;13(7):1364. doi: 10.3390/v13071364.